Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

LSP Leads €21m Series B Round of Neurent Medical (2021-01-20)
LSP, one of Europe’s leading life sciences and healthcare investors, today announced its investment in Neurent Medical, an Irish medical device company pioneering innovative treatments for chronic inflammatory diseases of the sinuses and nasal passages. The €21 mil...
Boehringer & Enara Bio Partner for Cancer Immunotherapy (2021-01-12)
> Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers > Latest in a series of strategic acquisitions and partnerships that strengthens Boehringer Ingelheim’s position in the cancer vaccine and T-cell engager spaces > Agreement...
€50m Launch of LSP Dementia Fund, Targets €150m (2021-01-12)
LSP, the leading European life sciences investor, today announces the launch of the LSP Dementia Fund, a fund dedicated to fight neurodegenerative diseases. The fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought lead...
Novartis Licenses Tislelizumab from BeiGene, $650m Upfront (2021-01-11)
> Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and long-term growth > Novartis secures development and commercialization rights in North America, Europe, and Japan...
Immunocore: $75m Series C Round & $100m Loan Facility (2021-01-11)
Funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma Immunocore, a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapi...
Affimed: up to $25m in Term Loans from SVB (2021-01-11)
€10 million available at closing and up to €15 million available upon achievement of certain milestones Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announce...
Sanofi to Acquire Kymab for up to $1.45b (2021-01-11)
Continues to build on Sanofi’s leading presence in immunology aligned with strategy to pursue best-in-class treatments in defined areas Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on im...
Advicenne Appoints Peter Meeus as CEO (2021-01-07)
Advicenne (Paris:ADVIC) (BSE:ADVIC) (Euronext: ADVIC) today announced the appointment of Peter Meeus as Chief Executive Officer of Advicenne, effective February 15, 2021 . Dr. André Ulmann, who has been serving as interim CEO, will assume the position of Chief Medi...
Qiagen to Distribute Sanger Institute’s COSMIC Database (2021-01-07)
> Exclusive sales, marketing, support and distribution by QIAGEN > Including over 71 million cancer mutations, the COSMIC Database joins QIAGENs’ portfolio for cancer genomic analysis and interpretation > Agreement effective from January 1, 2021 QIAGEN a...
PerkinElmer to Acquire Oxford Immunotec for $591m in Cash (2021-01-07)
> PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash > Transaction expected to be completed in the first half of 2021 PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or th...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)